Mo, C., C. Gasparetto, C. Costa, A.J. Cowan, T. Mark, Y. Chai, T. Kashyap, J. Katz, M. Amatangelo, and P.G. Richardson. 2026. “P43 | SELINEXOR, MEZIGDOMIDE, AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RELAPSED OR ARE INELIGIBLE FOR T-CELL–REDIRECTING THERAPY: STOMP PHASE 1 PRELIMINARY RESULTS”. Haematologica 111 (s2). Pavia, Italy. https://doi.org/10.3324/haematol.2026.s2.14043.